Search

everythinglearnresearchcommunity

for

Search:↓

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

A 25-year-old man with multiple skin tumors was successfully treated with acitretin and methotrexate.

A new method helps manage skin side effects from hormonal cancer therapy, improving patient care.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.

Imuvert can prevent some chemotherapy-induced hair loss.

GT20029 showed some hair growth improvement, but longer studies are needed for better results.

Photodynamic therapy was effective in treating multiple scalp basal cell carcinomas with minimal side effects and good cosmetic results.

Mitotane changes steroid breakdown, affecting cortisol availability.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Chemotherapy and radiotherapy can cause skin side effects like rashes, hair loss, and nail changes, which are usually managed with conservative treatments.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair cells.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Photobiomodulation therapy may speed up hair regrowth after chemotherapy in the short term.

ALRN-6924 may prevent hair loss caused by chemotherapy.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Low-intensity ultrasound may protect hair follicles from damage caused by a common chemotherapy drug.

Cancer treatments often cause skin, nail, and hair problems.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Chrysin makes docetaxel more effective and reduces its side effects in lung cancer treatment.

Dutasteride effectively increases hair density in women with hair loss.

Botulinum neurotoxin A is effective and safe for treating various conditions, but more clinical trials are needed to fully assess its benefits and risks.

Radiotherapy can cause rare changes in hair color, which should be discussed with patients.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Recognizing and managing skin side effects from chemotherapy improves patient quality of life and treatment success.

A standardized scoring system is needed to improve model reliability for predicting hair loss in brain tumor patients treated with proton therapy.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

RC48 shows promise for treating certain advanced cancers, but more research is needed.